Latest NewsUSFDA issues 7 observations to Biocon’s Bengaluru facilityadminMay 3, 2018 by adminMay 3, 20180857 The US health regulator, has issued 7 observations to Biocon’s sterile drug product manufacturing facility in Bengaluru, after inspection. In a filing to the BSE the...